M2 Archive: Preview
You haven't logged in. If you have archive credits in your account, please log in now to use them. If not, you can buy credits in our shopping area.
Amarantus BioScience Holdings Inc reports encouraging orphan data for MANF in Retinitis Pigmentosa, qualifying as first orphan indication in ophthalmology
Biotechnology company Amarantus BioScience Holdings Inc (OTC Markets:AMBS) on Monday provided positive data for MANF in the degenerative disease, Retinitis Pigmentosa (RP).
According to the data from the study, the intravitreal injection of recombinant human MANF protein protects both rods...
If you want to view the full text, you must first purchase archive credits.
Return to Archives